The Patent Finder

Engineered Nucleic Acids Encoding a Modified Erythropoietin and Their Expression

ModernaTX, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 9 of these applications claim priority to application 61/470,451, filed Mar 31, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,710,200Engineered Nucleic Acids Encoding a Modified Erythropoietin and Their Expression
In force
 · High confidence
ModernaTX, Inc.In force
High confidence
US 9,533,047Delivery and Formulation of Engineered Nucleic Acids
In force
 · High confidence
ModernaTX, Inc.In force
High confidence
US 9,950,068Delivery and Formulation of Engineered Nucleic Acids
In force
 · High confidence
ModernaTX, Inc.In force
High confidence
US 10,898,574Delivery and Formulation of Engineered Nucleic Acids
In force
 · High confidence
ModernaTX, Inc.In force
High confidence
US 11,911,474Delivery and Formulation of Engineered Nucleic Acids
In force
 · High confidence
ModernaTX, Inc.In force
High confidence
US 12,364,763Delivery and Formulation of Engineered Nucleic Acids
In force
 · High confidence
ModernaTX, Inc.In force
High confidence
US 12,409,226Delivery and Formulation of Engineered Nucleic Acids
In force
 · High confidence
ModernaTX, Inc.In force
High confidence
US 12,419,957Delivery and Formulation of Engineered Nucleic Acids
In force
 · High confidence
ModernaTX, Inc.In force
High confidence
US 12,502,431Delivery and Formulation of Engineered Nucleic Acids
In force
 · High confidence
ModernaTX, Inc.In force
High confidence
Application 13/897,362Modified Polynucleotides for the Production of Factor IX
Abandoned
Abandoned Aug 24, 2015
ModernaTX, Inc.AbandonedAbandoned Aug 24, 2015
1 more patent in this group · Pro
10 of 11 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 11.
Upgrade to Pro
9 of these are in force and held by ModernaTX, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited